IE40930B1 - Decapeptides - Google Patents
DecapeptidesInfo
- Publication number
- IE40930B1 IE40930B1 IE2036/74A IE203674A IE40930B1 IE 40930 B1 IE40930 B1 IE 40930B1 IE 2036/74 A IE2036/74 A IE 2036/74A IE 203674 A IE203674 A IE 203674A IE 40930 B1 IE40930 B1 IE 40930B1
- Authority
- IE
- Ireland
- Prior art keywords
- leu
- arg
- tyr
- glu
- ser
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1458685 Decapeptides AMERICAN HOME PRODUCTS CORP 25 Sept 1974 [3 Oct 1973 21 Nov 1973] 41612/74 Heading C3H Peptides of Formula (I) wherein X is Ala or Leu, and the non-toxic salts thereof (hydrocholoride, hydrobromide, sulphate, phosphate, maleate, acetate, citrate, benzoate, succinate, malate or ascorbate). Derivatives of (I) of Formula (II) wherein N<SP>9</SP> represents side chain nitrogen atoms of Arg, R is NH 2 , OH, O-(lower)alkyl ("lower" being C 1-6 ), O-benzyl, R<SP>1</SP> is a protecting group for the N<SP>8</SP>, N<SP>#</SP>, N<SP>#1</SP> atoms of Arg, and is nitro, tosyl, benzyloxycarbonyl or adamantyloxycarbonyl (if R<SP>1</SP> is nitro or tosyl, protection is on either the N<SP>#</SP> or N<SP>#1</SP> and, if R<SP>1</SP> is benzyloxycarbonyl or adamantyloxycarbonyl, protection is on N<SP>#</SP> and either N<SP>#</SP> or N<SP>#1</SP>); R<SP>2</SP> is a protecting group for the phenolic hydroxyl of Tyr and is acetyl, tosyl, benzoyl, t-butyl, tetrahydropyranyl, trityl, benzyl, 2,4-dichlorobenzyl or benzyloxycarbonyl; R<SP>3</SP> is a protecting group for the alcoholic hydroxyl of Ser and is one specified for R<SP>2</SP>; R<SP>4</SP> is an aminoprotecting group or hydrogen; wherein R<SP>1</SP>, R<SP>2</SP> or R<SP>3</SP> may also be hydrogen, with the proviso that at least one of R<SP>1</SP>, R<SP>2</SP> and R<SP>3</SP> is a protecting group and the non-toxic salts thereof. Derivatives of (II) of Formula (III) wherein R<SP>5</SP> is R<SP>4</SP>-(Pry)Glu, an α-aminoprotecting group or hydrogen; and A represents one of Preferred resins are benzhydrilamine, chloromethylated or hydroxymethyl styrene resins. The peptides may be prepared by Merrifield synthesis, to yield (III), followed by either (i) a one step cleavage and deprotection to yield (I) or (ii) cleavage to yield (II) followed by deprotection. Step (i) may be effected with hydrogen fluoride using benzhydrilamine resin, and step (ii) ammonolysis using a chloromethylated or hydroxymethyl resin. In the examples, the following peptides were prepared: H-(Pyr)Glu-D-Phe-Trp- Ser(Bzl) - Tyr(Bzl) - D - Ala - Leu- Arg(NO 2 ) - Pro - Gly benzhydrilamine resin; H - (Pyr)Glu - D - Phe - Trp - Ser- Tyr - D - Ala - Leu - Arg - Pro - Gly- NH 2 and acetate; H-(Pyr)Glu-D-Phe- Trp - Ser(Bzl) - Tyr(Bzl) - D - Leu- Leu - Arg(NO 2 ) - Pro - Gly benzhydrilamine resin; H - (Pyr)Glu - D - Phe - Trp- Ser - Tyr - D - Leu - Leu - Arg - Pro- Gly.NH 2 and acetate. Pharmaceutical compositions, for the inhibition of ovulation in female mammals, comprises a peptide of Formula (I) or a non-toxic salt thereof and a pharmaceutically acceptable carrier, said composition may be in unit dosage form.
[GB1458685A]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00402958A US3855199A (en) | 1973-10-03 | 1973-10-03 | P-glu-d-phe-t rp-ser-tyr-d-ala-leu-arg-pro-gly-nh2-and intermediates |
US417983A US3886137A (en) | 1973-11-21 | 1973-11-21 | P-Glu-D-Phe-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-Gly-NH{HD 2 {B and intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
IE40930L IE40930L (en) | 1975-04-03 |
IE40930B1 true IE40930B1 (en) | 1979-09-12 |
Family
ID=27018102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2036/74A IE40930B1 (en) | 1973-10-03 | 1974-10-01 | Decapeptides |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5059367A (en) |
CA (1) | CA1022546A (en) |
CH (1) | CH605676A5 (en) |
DE (1) | DE2447097A1 (en) |
FR (1) | FR2247254B1 (en) |
GB (1) | GB1458685A (en) |
IE (1) | IE40930B1 (en) |
NL (1) | NL7413081A (en) |
NZ (1) | NZ175566A (en) |
PH (1) | PH11571A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4409208A (en) * | 1980-04-15 | 1983-10-11 | The Salk Institute For Biological Studies | GnRH antagonists |
DE3842010A1 (en) * | 1988-12-14 | 1990-06-21 | Hoechst Ag | COMPETITIVE GONADOLIBERINE ANTAGONISTS |
-
1974
- 1974-09-20 PH PH16314A patent/PH11571A/en unknown
- 1974-09-23 CA CA209,974A patent/CA1022546A/en not_active Expired
- 1974-09-25 GB GB4161274A patent/GB1458685A/en not_active Expired
- 1974-10-01 NZ NZ175566A patent/NZ175566A/en unknown
- 1974-10-01 IE IE2036/74A patent/IE40930B1/en unknown
- 1974-10-02 FR FR7433242A patent/FR2247254B1/fr not_active Expired
- 1974-10-02 DE DE19742447097 patent/DE2447097A1/en not_active Withdrawn
- 1974-10-02 JP JP49114274A patent/JPS5059367A/ja active Pending
- 1974-10-02 CH CH1327474A patent/CH605676A5/xx not_active IP Right Cessation
- 1974-10-03 NL NL7413081A patent/NL7413081A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IE40930L (en) | 1975-04-03 |
DE2447097A1 (en) | 1975-04-10 |
CA1022546A (en) | 1977-12-13 |
PH11571A (en) | 1978-03-31 |
NZ175566A (en) | 1978-06-20 |
CH605676A5 (en) | 1978-10-13 |
JPS5059367A (en) | 1975-05-22 |
GB1458685A (en) | 1976-12-15 |
NL7413081A (en) | 1975-04-07 |
AU7352074A (en) | 1976-03-25 |
FR2247254A1 (en) | 1975-05-09 |
FR2247254B1 (en) | 1980-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4689396A (en) | GnRH antagonists V | |
EP0100218B1 (en) | Gnrh antagonists | |
US4253997A (en) | Anti-ovulatory decapeptides | |
US4565804A (en) | GnRH Antagonists VI | |
CA2029678A1 (en) | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14 | |
US4569927A (en) | GnRH Antagonists IV | |
CA2012480A1 (en) | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 | |
AU3132489A (en) | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | |
US5073624A (en) | Therapeutic decapeptides | |
US4652550A (en) | GnRH antagonists VII | |
EP0162575B1 (en) | Gnrh antagonists vii | |
GB1535602A (en) | Lhrh peptide derivatives | |
EP0063423B1 (en) | Gnrh antagonists | |
US4619914A (en) | GNRH antagonists IIIB | |
US4740500A (en) | GnRH antagonists VIII | |
IE40930B1 (en) | Decapeptides | |
US4034082A (en) | Method to prevent reproduction in warm-blooded female animals with nonapeptides | |
GB1473020A (en) | Peptides | |
US4377574A (en) | Contraceptive treatment of male mammals | |
EP0038135B1 (en) | Lrf antagonists | |
US4489061A (en) | Treatment of male mammals | |
US5618791A (en) | Memory enhancing peptides | |
US4386074A (en) | LRF Antagonists | |
Erchegi et al. | LH-RH antagonists: further analogs with ring-substituted aromatic residues | |
IE58287B1 (en) | Spiro-heteroazolones for treatment of diabetes complications |